Last reviewed · How we verify
NCT04443075: AGMFMSS
Alterations of Gut Microbiome in the Frontline Medical Staff Under the Stress
trial testing faecal sample collector in Stress Disorders, Post-Traumatic in 180 participants. Completed in 24 December 2020.
4 December 2020
Quick facts
| Lead sponsor | First Affiliated Hospital Xi'an Jiaotong University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 180 |
| Start date | 24 June 2020 |
| Primary completion | 4 December 2020 |
| Estimated completion | 24 December 2020 |
| Sites | 1 location across China |
Drugs / interventions tested
- faecal sample collector
Conditions studied
- Stress Disorders, Post-Traumatic — all drugs for Stress Disorders, Post-Traumatic →
Sponsor
First Affiliated Hospital Xi'an Jiaotong University
Who can join
Adults 18 to 50, any sex, with Stress Disorders, Post-Traumatic. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
With the outbreak of 2019 novel coronavirus (2019-nCoV), the frontline medical workers faced enormous stress, including a high risk of infection and inadequate protection from contamination, isolation, patients with negative emotions, a lack of contact with their families, and exhaustion, which may cause mental health problems. The investigators plan to collect the faecal samples and clinical assessments from a part of frontline medical workers in three time points to analyse the changing profile of gut microbiome according to outcomes of 16s rRNA sequencing. The samples from the matched health controls will also be sequenced to compare with the exposed group in gut microbiome community.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Lost microbes of COVID-19: <i>Bifidobacterium</i>, <i>Faecalibacterium</i> depletion and decreased microbiome diversity associated with SARS-CoV-2 infection severity.
Hazan S, Stollman N, Bozkurt HS, Dave S, et al · · 2022 · cited 66× · PMID 35483736 · DOI 10.1136/bmjgast-2022-000871 -
Stressful events induce long-term gut microbiota dysbiosis and associated post-traumatic stress symptoms in healthcare workers fighting against COVID-19.
Gao F, Guo R, Ma Q, Li Y, et al · · 2022 · cited 53× · PMID 35157946 · DOI 10.1016/j.jad.2022.02.024 -
The lost microbes of COVID-19: Bifidobacterium, Faecalibacterium depletion and decreased microbiome diversity associated with SARS-CoV-2 infection severity
Hazan S, Stollman N, Bozkurt H, Dave S, et al · · 2021 · DOI 10.1101/2021.09.02.21262832
Verify or expand the search:
- PubMed search for NCT04443075
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Stress Disorders, Post-Traumatic
Currently open trials in the same condition.
- NCT07422077 — Impact of ERCS on Perceived Stress in Patients Hospitalized in the Post-resuscitation Rehabilitation Service · NA · recruiting
- NCT07010770 — SMART Therapist Training: A Hybrid Factorial-SMART Design · NA · recruiting
- NCT06852469 — Computational Assessment of GABA Receptor Modulation in PTSD · Phase 4 · recruiting
- NCT06000475 — Enhancing Memory in CPT for PTSD · NA · recruiting
- NCT06355284 — Overcontrol and Suicide in PTSD · active not recruiting
Other First Affiliated Hospital Xi'an Jiaotong University trials
Trials by the same sponsor.
- NCT07389460 — Intravenous rhPro-UK Before Stroke Thrombectomy in the Extended Time Window (BRIDGE-PUK EXTEND) · Phase 3 · not yet recruiting
- NCT07170176 — Effects of PFO Closure on Glymphatic Function and Clinical Symptoms in Patients With Migraine · NA · recruiting
- NCT07168291 — Novel Bispecific AbTCR (Anti-CD19/CD22)-T Cells in Relapsed or Refractory B-cell Lymphoma · EARLY_PHASE1 · not yet recruiting
- NCT06775782 — Remote Ischemic Conditioning for Acute Moderate Ischemic Stroke Due to Large Artery Atherosclerosis · NA · recruiting
- NCT07266467 — Efficacy and Safety of Leymovir Versus Valganciclovir in Prevention of Cytomegalovirus Infection and Cytomegalovirus Dis · Phase 4 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04443075 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by First Affiliated Hospital Xi'an Jiaotong University
- Last refreshed: 3 March 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04443075.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing